Each year, the U.S. sees roughly 30,000 cases of invasive pneumococcal disease, which includes blood infections, brain and ...

The recommended first age at which Americans should get the pneumococcal vaccine has been lowered from 65 to 50, the U.S.

As we enter the colder parts of the year.. chances of catching respirotory illnesses increase.This year.. the C-D-C is ...

The Centers for Disease Control and Prevention has released new guidance on the recommended age for those who should get a ...

U.S. health officials have recommended that adults aged 50 and older receive a pneumococcal vaccine to protect against ...

The CDC currently recommends shots for children ... About 30% of cases are among 50- to 64-year-olds. The first pneumococcal vaccine was licensed in the U.S. in 1977, and since then pharmaceutical ...

(Reuters) -Advisers to the Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults between 50-64 years to protect against pneumococcal disease. The ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results ... although – following the Capvaxive approval – the CDC's Advisory Committee on Immunisation Practices (ACIP) is ...

The CDC’s Advisory Committee on Immunization ... and that age-targeted approach is central to MSD’s targeted pneumococcal vaccine strategy. It is also deploying its age-targeted serotype ...

The Centers for Disease Control and Prevention (CDC) is scheduled to review ... Prior to COVID-19, pneumococcal vaccines were the largest vaccine market worldwide – estimated at around $8 ...